Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record for the Phase 3 RC48-ADC breast cancer trial is displayed, including its eligibility criteria, treatment comparisons, outcome measures, recruiting status, and study contacts.
    Difference
    94%
    Check dated 2026-11-11T01:18:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T23:35:22.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” above the ClinicalTrials.gov 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:24:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site revision footer changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:21.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating the study record is inaccessible at this URL. The page shows a standard error screen with a Home link, suggesting restricted access rather than a loaded study record.
    Difference
    23%
    Check dated 2026-09-22T23:37:23.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows an updated revision tag to v3.7.0, replacing the previous v3.6.6; this signals a page version update without altering trial information.
    Difference
    0.0%
    Check dated 2026-09-15T22:48:51.000Z thumbnail image

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.